Excel Industries Q1 Revenue at ₹290 Crore, Standalone Net Profit Falls to ₹29.1 Crore

Market snapshot: Excel Industries Limited has reported its financial performance for the first quarter of FY27 ended June 30, 2026. The company experienced a decline in top-line revenue and standalone net profit, though cost optimizations helped generate minor expansions in operational margins.

Data Snapshot

• Standalone revenue from operations dropped to ₹290 cr from ₹310 cr YoY.
• Operating EBITDA marginally grew to ₹42.4 cr compared to ₹42.2 cr YoY.
• EBITDA margin improved by 81 bps to 14.45% from 13.64% YoY.
• Standalone net profit fell to ₹29.1 cr from ₹33.8 cr YoY.

What's Changed

• Revenue from operations fell by ₹20 cr, down to ₹290 cr from ₹310 cr in Q1 FY26.
• Operational profitability improved as EBITDA margin rose to 14.45% compared to 13.64% YoY.
• Net Profit dropped to ₹29.1 cr from ₹33.8 cr, showing bottom-line deceleration.

Key Takeaways

• Agrochemical Headwinds: A temporary demand slowdown in the core agrochemicals intermediates segment has directly impacted the company's top-line revenue.
• Operational Margins Expand: Excel Industries registered a 14.45% (derived: 14.45% vs 13.64% YoY) EBITDA margin, reflecting strong cost optimization and inventory management.
• Stable EBITDA: Operating EBITDA remained resilient at ₹42.4 cr, marking a slight growth of ≈0.47% YoY (derived: ₹42.4 cr vs ₹42.2 cr).
• Net Profit Contraction: Standalone net profit decreased to ₹29.1 cr from ₹33.8 cr YoY, likely owing to muted sequential demand and fixed operational costs.

SAHI Perspective

Excel Industries is actively transitioning to reduce its structural reliance on highly cyclical agrochemical intermediates, which typically account for 50-60% of its revenues. Despite seasonal headwinds dropping the top-line, the company's ability to defend and expand its EBITDA margin to 14.45% is a strong sign of pricing discipline. Capitalizing on high-margin performance solutions and contract manufacturing deals will remain critical for secular re-rating.

Market Implications

The combination of profit degrowth and revenue decline may trigger mild short-term selling pressure on the stock. However, structural cost containment and stable operating margins limit downside risk.

Trading Signals

Market Bias: Neutral

Standalone net profit dropped to ₹29.1 crore alongside a revenue dip to ₹290 crore, but EBITDA margin expanded to 14.45%. Mixed structural indicators keep near-term bias neutral.

Overweight: Specialty Chemicals

Underweight: Agrochemicals

Trigger Factors:

• Timely operationalization of the ₹5.05 crore greenfield unit at Lote by February 2027.
• Revenue realization and scaling from the 5-year specialty chemicals supply agreement.
• Recovery in global and domestic agrochemical intermediates demand.

Time Horizon: Medium-term (3–12 months)

Industry Context

The Indian specialty chemical sector is showing early signs of margin recovery despite global destocking. Agrochemical intermediate margins have faced pressure, pushing players like Excel Industries and Sumitomo Chemical India to aggressively pivot toward contract manufacturing and downstream performance solutions.

Key Risks to Watch

• Prolonged recovery timeline for the global agrochemicals intermediates segment.
• Fluctuations in key raw material input prices.
• Execution delays in commissioning the 1,265 MTPA Lote specialty chemicals unit.

Recent Developments

Excel Industries announced a ₹5.05 crore investment to establish a new 1,265 MTPA specialty chemical manufacturing facility at its Lote site, with an expected launch by February 2027. Additionally, the company successfully completed a project for a 5-year contract manufacturing agreement of specialty chemicals, projected to yield ₹35-40 crore in net income annually. Shareholder approval was also obtained for the appointment of Mr. Mahtabuzzaman as Nominee Director.

Closing Insight

While short-term cyclical headwinds impact top-line numbers, Excel Industries' focus on margin defense and high-value contract manufacturing projects positions it well to capture structurally superior profitable growth as market cycles normalize.

High Performance Trading with SAHI.